The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
NHS England devolution: In a significant shake-up, the government plans to abolish NHS England, aiming to streamline bureaucracy and accelerate healthcare delivery. This controversial move grants more autonomy to ICBs, potentially speeding up crucial infrastructure projects and enhancing patient care.
Study suggests that long COVID patients are more likely to face blood-clots - even if they appeared okay, their clotting biomarkers were significantly high.
Professor Kjell Hausken at the University of Stavanger discusses his research into energy expenditure through combining different types of exercise classes.
Peter Masonbrook from Faithful+Gould and Penny Anderson from Atkins discuss the role and importance of social value within the public and private sector.
Mark Reynolds, Chief Technology Officer at NHS Digital, talks about the unique challenges brought about by the pandemic, and how using data innovatively with the Shielded Patient List and Population Risk Assessment helped to identify and protect some of the most vulnerable in society.
Francesca Gargaglia, COO and CBO, Amity, argues that although social media platforms should be responsible for preventing the spread of COVID-19 misinformation, government agencies should build their own communities that build trust and promote well-informed discussions.
The US Food and Drug Administration (FDA) have approved a third Pfizer dose for people who are immunocompromised - despite the WHO asking countries to wait until 20% were double-vaccinated, globally.
Sir Andrew Pollard, head of the Oxford Vaccine Group, said on Tuesday (10 August) that herd immunity is "mythical" in relation to the Delta variant - as it still infects vaccinated individuals.
Physicians at University of California San Diego School of Medicine describe the first known case of a young, healthy adult who suffered brain inflammation after mild COVID-19 infection.
